Operating Lease, Right-of-Use Asset of Unity Biotechnology, Inc. from 31 Dec 2018 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Unity Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Mar 2025.
  • Unity Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $8,455,000, a 32% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $8,455,000 -$3,986,000 -32% 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $8,900,000 -$4,081,000 -31% 31 Dec 2024 10-Q 22 Apr 2025 2025 Q1
Q3 2024 $11,359,000 -$2,163,000 -16% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $11,900,000 -$6,161,000 -34% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $12,441,000 -$6,116,000 -33% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $12,981,000 -$6,061,000 -32% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $13,522,000 -$5,993,000 -31% 30 Sep 2023 10-K 15 Apr 2024 2023 FY
Q2 2023 $18,061,000 -$2,055,000 -10% 30 Jun 2023 10-K 15 Apr 2024 2023 FY
Q1 2023 $18,557,000 -$2,149,000 -10% 31 Mar 2023 10-K 15 Apr 2024 2023 FY
Q4 2022 $19,042,000 -$2,244,000 -11% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 $19,515,000 -$2,341,000 -11% 30 Sep 2022 10-K 15 Apr 2024 2023 FY
Q2 2022 $20,116,000 -$2,300,000 -10% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $20,706,000 -$2,261,000 -9.8% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $21,286,000 -$2,223,000 -9.5% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $21,856,000 -$2,474,000 -10% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $22,416,000 -$2,475,000 -9.9% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $22,967,000 -$2,476,000 -9.7% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $23,509,000 +$23,509,000 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $24,330,000 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $24,891,000 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $25,443,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $0 $0 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q4 2018 $0 31 Dec 2018 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.